This week, we’re joined by Sébastien Béguerie, entrepreneur and founder of Kanavape, Alpha-Cat and Golden Buds. 

Together we examine the methodologies and tests involved in the quality control of cannabis, their challenges, and the barriers to achieving consistent quality. Sébastien also shares his reflections on the Kanavape case – a significant milestone for the European CBD industry.

→ View full show notes, summary, and access resources here:
https://www.canverse.global/shownotes/e125

About Sébastien Béguerie

Sebastien is one of Europe’s leading experts in medical cannabis and CBD with more than 10 years of experience in cannabis production, regulation, education, and advocacy.  Sébastien Béguerie holds an MSc in Plant Sciences, from Wageningen University Research in The Netherlands where he was kindly sponsored by Bedrocan. In 2009, he co-founded the first national medical Cannabis French patient association –  “l’ Union Francophone pour les Cannabinoids en Médecine” (UFCM). Together with the association, Sébastien organises the international medical Cannabis conference in Strasbourg. In 2011 Sébastien founded his Alpha-cat in Europe, who manufacture cannabinoid testing kits and CBD products. In 2015, Sébastien created and launched the famous Kanavape brand in Europe which was the first CBD -cigarette to be sold in the region. In 2020 Sebastien started Golden Buds a new CBD brand mixing Californian CBD product innovation, with French luxury.

Resources
Follow Sébastien on LinkedIn: https://www.linkedin.com/in/sebastienbeguerie/?originalSubdomain=fr
Follow Sébastien on Instagram: https://www.instagram.com/alphacat_420/?hl=en
Golden Buds Website: https://www.goldenbuds.eu/
Alpha-Cat Website: https://www.alpha-cat.org/

source